Nerve growth factor blockade for the management of osteoarthritis pain: what can we learn from clinical trials and preclinical models?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Opinion in Rheumatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/BOR.0000000000000354PMID 27672741PMCID PMC5436144
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The anti-NGF antibody muMab 911 both prevents and reverses pain behaviour and subchondral osteoclast numbers in a rat model of osteoarthritis pain

  2016cited by this paper
• Tanezumab for Patients with Osteoarthritis of the Knee: A Meta-Analysis

  2016cited by this paper
• PKCδ null mutations in a mouse model of osteoarthritis alter osteoarthritic pain independently of joint pathology by augmenting NGF/TrkA-induced axonal outgrowth

  2016cited by this paper
• When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program

  2016cited by this paper
• Efficacy and safety of fulranumab as monotherapy in patients with moderate to severe, chronic knee pain of primary osteoarthritis: a randomised, placebo‐ and active‐controlled trial

  2016cited by this paper
• Emerging Targets for the Management of Osteoarthritis Pain

  2016cited by this paper
• Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administration.

  2016cited by this paper
• Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model

  2016cited by this paper
• A Feline‐Specific Anti‐Nerve Growth Factor Antibody Improves Mobility in Cats with Degenerative Joint Disease–Associated Pain: A Pilot Proof of Concept Study

  2016cited by this paper
• Anti-nerve growth factor in pain management: current evidence

  2016cited by this paper
• Role of nerve growth factor in pain.

  2015cited by this paper
• A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain

  2015cited by this paper
• Long-term analgesic effect of a single dose of anti-NGF antibody on pain during motion without notable suppression of joint edema and lesion in a rat model of osteoarthritis.

  2015cited by this paper
• Blocking the tropomyosin receptor kinase A (TrkA) receptor inhibits pain behaviour in two rat models of osteoarthritis

  2015cited by this paper
• Deficits in spontaneous burrowing behavior in the rat bilateral monosodium iodoacetate model of osteoarthritis: an objective measure of pain-related behavior and analgesic efficacy.

  2015cited by this paper
• Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.

  2015cited by this paper
• Drug developers reboot anti-NGF pain programmes

  2015cited by this paper
• Efficacy of a novel, locally delivered TrkA inhibitor in preclinical models of OA and joint pain

  2015cited by this paper
• A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee.

  2015cited by this paper
• Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies.

  2015cited by this paper
• Targeting Nerve Growth Factor (NGF) for Pain Management: What Does the Future Hold for NGF Antagonists?

  2014cited by this paper
• A commentary on modelling osteoarthritis pain in small animals.

  2013cited by this paper
• Nerve growth factor: an update on the science and therapy.

  2013cited by this paper
• Efficacy and safety of intravenous immunoglobulin as adjuvant treatment for refractory neuropathic pain. Results of an open-label, multicenter study.

  2012cited by this paper
• Antagonism of Nerve Growth Factor-TrkA Signaling and the Relief of Pain

  2011influential reference
• Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non‐inflammatory joint pain

  2010cited by this paper
• Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis

  2010cited by this paper
• Tanezumab for the treatment of pain from osteoarthritis of the knee.

  2010cited by this paper
• The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse.

  2010cited by this paper
• The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rat.

  2010cited by this paper
• Anti-inflammatory actions of intravenous immunoglobulin.

  2008cited by this paper
• Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis

  2007cited by this paper
• Rita Levi-Montalcini: the discovery of nerve growth factor and modern neurobiology.

  2004cited by this paper
• Nerve growth factor-induced hyperalgesia in the neonatal and adult rat

  1993cited by this paper
• Effects of long-term nerve growth factor deprivation on the nervous system of the adult rat: an experimental autoimmune approach.

  1980cited by this paper
• Immunization of adult rats against 2.5 S NGF: effects on the peripheral sympathetic nervous system.

  1979cited by this paper
• Biochemical effects of antibodies against nerve growth factor on developing and differentiated sympathetic ganglia.

  1978cited by this paper
• Ultrastructural changes in sympathetic neurons of newborn and adult mice treated with nerve growth factor.

  1971cited by this paper

• A small lipidated peptide targeting NaV1.8 channels attenuates osteoarthritic pain behavior and prevents bone erosion

  2026cites this paper
• Advancing Early Detection of Osteoarthritis Through Biomarker Profiling and Predictive Modelling: A Review

  2025cites this paper
• From neuromodulation to bone homeostasis: therapeutic targets of nerve growth factor in skeletal diseases

  2025cites this paper
• Translational validity of quantitative sensory testing in chronic pain neuro-sensitization: guide of use and interpretation in osteoarthritis animal models

  2025cites this paper
• Organ-on-chip technologies: Novel tools with the potential to revolutionize osteoarthritis research and clinical development

  2025cites this paper
• Preclinical Perspectives on Disorders of the Temporomandibular Joint: Tracing the Past, Navigating the Present, and Shaping the Future.

  2025cites this paper
• The Implications of Brain-Derived Neurotrophic Factor in the Biological Activities of Platelet-Rich Plasma

  2024cites this paper
• Pain Management Strategies in Osteoarthritis

  2024cites this paper
• Targeting an inflammation-amplifying cell population can attenuate osteoarthritis-associated pain

  2024cites this paper
• Pain-phenotyping in osteoarthritis: Current concepts, evidence, and considerations towards a comprehensive framework for assessment and treatment

  2024cites this paper
• Expression of CGRP in the Trigeminal Ganglion and Its Effect on the Polarization of Macrophages in Rats with Temporomandibular Arthritis

  2024cites this paper
• Macrophage and chondrocyte phenotypes in inflammation

  2024cites this paper
• Pain sensitivity genes as therapeutic targets in knee osteoarthritis: A comprehensive analysis

  2024cites this paper
• NGF-BMSC-SF/CS composites for repairing knee joint osteochondral defects in rabbits: evaluation of the repair effect and potential underlying mechanisms

  2024cites this paper
• High efficiency protocol for platelet derived fibrin gel loaded with mesenchymal stromal cells extracellular vesicles

  2024cites this paper
• Pharmacotherapy for osteoarthritis-related pain: current and emerging therapies

  2024cites this paper
• Anti-NGF treatment worsens subchondral bone and cartilage measures while improving symptoms in floor-housed rabbits with osteoarthritis

  2023cites this paper
• Inflammation in osteoarthritis: our view on its presence and involvement in disease development over the years.

  2023cites this paper
• Various Doses of Tanezumab in the Management of Chronic Low Back Pain (CLBP): A Pooled Analysis of 4,514 Patients

  2023cites this paper
• The degeneration-pain relationship in the temporomandibular joint: Current understandings and rodent models

  2023cites this paper
• Long March Toward Safe and Effective Analgesia by Enhancing Gene Expression of Kcc2: First Steps Taken

  2022cites this paper
• The Multifaceted Role of Mast Cells in Joint Inflammation and Arthritis.

  2022cites this paper
• Interleukin-6 signaling mediates cartilage degradation and pain in posttraumatic osteoarthritis in a sex-specific manner

  2022cites this paper
• The neuronal tyrosine kinase receptor ligand ALKAL2 mediates persistent pain

  2022cites this paper
• Neuropathic-like Pain in Fibrous Dysplasia/McCune-Albright Syndrome

  2022cites this paper
• Les traitements en cours de développement dans l’arthrose

  2021cites this paper
• Receptor and Molecular Targets for the Development of Novel Opioid and Non-Opioid Analgesic Therapies.

  2021cites this paper
• Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases

  2021cites this paper
• New Trends in Pharmacological Treatments for Osteoarthritis

  2021cites this paper
• Inflammation, angiogenesis and sensory nerve sprouting in the synovium of bony ankylosed and not bony ankylosed knees with end‐stage haemophilic arthropathy

  2021cites this paper
• The Role of Anti-Nerve Growth Factor Monoclonal Antibodies in the Control of Chronic Cancer and Non-Cancer Pain

  2021cites this paper
• Neuroimmune interactions in painful TMD: Mechanisms and treatment implications

  2021cites this paper
• Molecular Classification of Knee Osteoarthritis

  2021cites this paper
• Interleukin-6 Signaling Mediates Cartilage Degradation and Pain in Post-Traumatic Osteoarthritis

  2021cites this paper
• Low-Input RNA-Sequencing in Patients with Cartilage Lesions, Osteoarthritis, and Healthy Cartilage

  2021cites this paper
• Effects of Tanezumab on Osteoarthritis of the Knee: A Systematic Review and Meta- Analysis

  2021cites this paper
• Osteoarthritis: Current Molecular Biomarkers and the Way Forward

  2020cites this paper
• Emerging pharmaceutical therapies for osteoarthritis

  2020cites this paper
• Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications

  2020cites this paper
• The evolution of nerve growth factor inhibition in clinical medicine

  2020cites this paper
• Acteoside Counteracts Interleukin-1β-Induced Catabolic Processes through the Modulation of Mitogen-Activated Protein Kinases and the NFκB Cellular Signaling Pathway

  2020cites this paper
• Contribution of nerves within osteochondral channels to osteoarthritis knee pain in humans and rats.

  2020cites this paper
• Osteoarthritis: Current Molecular Biomarkers and the Way Forward

  2020cites this paper
• Supportive Care for the Cancer Patient

  2020cites this paper
• Reorganization of functional brain network architecture in chronic osteoarthritis pain

  2020cites this paper
• Chondroprotective Actions of Selective COX-2 Inhibitors In Vivo: A Systematic Review

  2020cites this paper
• c-Jun/p38MAPK/ASIC3 pathways specifically activated by NGF through TrkA is crucial for mechanical allodynia development.

  2020cites this paper
• NGF-mediated photoablation of nociceptors reduces pain behavior in mice

  2019cites this paper
• Therapeutic options for targeting inflammatory osteoarthritis pain

  2019cites this paper
• Therapeutic developments in equine pain management.

  2019cites this paper
• Détection et validation de marqueurs épigénétiques d’atteinte nociceptive dans l’arthrose sur modèle expérimental murin

  2019cites this paper
• Systemic drugs with impact on osteoarthritis

  2019cites this paper
• A Holistic Approach to Pain Management in the Rheumatic Diseases

  2019cites this paper
• Nerve growth factor–mediated photoablation of nociceptors reduces pain behavior in mice

  2019cites this paper
• Des recommandations sur la prise en charge de la coxarthrose : lecture critique

  2019cites this paper
• A Tale of Two TrkA Inhibitor Trials: Same Target, Divergent Results.

  2019cites this paper
• Applications of RNA interference in the treatment of arthritis.

  2019cites this paper
• Systemic L-Buthionine -S-R-Sulfoximine Treatment Increases Plasma NGF and Upregulates L-cys/L-cys2 Transporter and γ-Glutamylcysteine Ligase mRNAs Through the NGF/TrkA/Akt/Nrf2 Pathway in the Striatum

  2019cites this paper
• Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety

  2019influential citation
• Peripheral Mechanisms Contributing to Osteoarthritis Pain

  2018cites this paper
• What is new in pain modification in osteoarthritis?

  2018cites this paper
• Osteoarthritis pain. Recent advances and controversies

  2018cites this paper
• Monoclonal Antibodies for Osteoarthritis of the Hip or Knee

  2018cites this paper
• Recent progress in non-opioid analgesic peptides.

  2018cites this paper
• Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis pain

  2017cites this paper
• Current status of nerve growth factor antibodies for the treatment of osteoarthritis pain.

  2017cites this paper
• Combining Human and Rodent Genetics to Identify New Analgesics

  2017cites this paper
• The need for fundamental reforms in the pain research field to develop innovative drugs

  2017cites this paper
• Osteoarthritis pain: What are we learning from animal models?

  2017cites this paper
• Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis pain

  2017cites this paper